Translate

Friday, March 23, 2018

thumbnail

FBIO Fortress Biotech, Inc. gains 35% Mar 23, 2018

Coronado Biosciences, Inc., a biopharmaceutical company, develops novel immunotherapy agents for the treatment of autoimmune diseases and cancer. Its principal pharmaceutical product candidates in clinical development include Trichuris suis ova or... http://www.priceseries.com/trade/FBIO-Fortress-Biotech-Inc-stock-gains-35-percent-a-Trade-Record-by-priceSeries-2018022120180323.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive